Overview

The POWERED Study: Prophylaxis With Metformin to Prevent PTDM

Status:
Active, not recruiting
Trial end date:
2022-05-01
Target enrollment:
Participant gender:
Summary
PrOphylaxis With mEtformin to pREvent PTDM: a single site, placebo controlled, double blind randomised clinical trial evaluating the effectiveness of metformin to prevent post-transplant diabetes in a cohort of patients undergoing renal transplantation.
Phase:
Phase 2
Details
Lead Sponsor:
Barts & The London NHS Trust
Treatments:
Metformin